Collection of biological samples to study systemic autoimmune diseases
Constitution of a Collection of Biological Samples With the Aim of Carrying Out Clinico-biological and Pathophysiological Investigations of Systemic Autoimmune Diseases
This study is collecting samples from people with autoimmune diseases like lupus and scleroderma to see if they can find new ways to diagnose and treat these conditions better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 6 Years to 99 Years |
| Sex | All |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Trial ID | NCT05251415 on ClinicalTrials.gov |
What this trial studies
This project aims to create a comprehensive collection of clinical and biological data from patients with systemic autoimmune diseases such as lupus, scleroderma, myositis, and vasculitis. By gathering biological samples, the study seeks to identify new biomarkers and enhance understanding of the physiopathological mechanisms underlying these conditions. The collected data will be made available to the medical and scientific communities to facilitate the development of new therapeutic strategies tailored to individual patient profiles. The study emphasizes the importance of early diagnosis and personalized treatment approaches.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with rare systemic autoimmune diseases or those with atypical presentations of such diseases.
Not a fit: Patients with known anemia, those under protective supervision, or pregnant or breastfeeding women may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic methods and more effective treatments for patients with systemic autoimmune diseases.
How similar studies have performed: Other studies focusing on the collection of biological samples for autoimmune diseases have shown promise in identifying biomarkers and improving treatment strategies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with rare systemic autoimmune diseases (lupus, scleroderma, myositis for example), * Patients with atypical presentations of documented or probable systemic autoimmune diseases, * Patients receiving, or likely to receive new, innovative therapies (new molecule on the market, gene therapy, cell therapy, etc.). Exclusion Criteria: * Known anemia and hemoglobin \<10 g / dl * Patients under protective supervision (guardianship, curators) * Pregnant or breastfeeding woman
Where this trial is running
Toulouse
- Purpan University Hospital — Toulouse, France (Recruiting)
Study contacts
- Principal investigator: Chloé BOST, MD, PhD — University Hospital, Toulouse
- Study coordinator: Chloé BOST, MD, PhD
- Email: bost.c@chu-toulouse.fr
- Phone: 5 61 77 61 44
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.